« Germany: The Bundeskartellamt's New Merger Guidelines | Main | UK: Clarification of the Litigation Privilege that can be Claimed by Parties During an Investigation by a Competition Authority »
September 5, 2012
The Application of EU Competition Law in the Pharmaceutical Sector
Posted by D. Daniel Sokol
David W. Hull (Covington) addresses The Application of EU Competition Law in the Pharmaceutical Sector.
ABSTRACT: If the Court of Justice follows the Advocate General's advice and upholds the General Court's judgment in AstraZeneca, this may result in increased enforcement aimed at various life cycle management strategies. The Commission's current enforcement priority remains combatting practices that slow generic entry, particularly reverse-payment patent settlements. The Commission has shown a renewed interest in parallel trade, particularly dual-pricing arrangements in Spain.
September 5, 2012 | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef017617011f66970c
Listed below are links to weblogs that reference The Application of EU Competition Law in the Pharmaceutical Sector:
